| – | Peak historical inhibitor titre ≤200 BU mL-1 |
| – | Inhibitor titre <10 BU mL-1 before ITI initiation |
| – | Peak inhibitor titre during ITI ≤200 BU mL-1 |
| – | Age <8 years at start of ITI |
| – | ITI initiated <5 years after inhibitor diagnosis |
| – | Interruptions in ITI <2 weeks in duration |
Mark T. Reding, MDAssociate Professor of Medicine Director, Center for Bleeding and Clotting Disorders University of Minnesota Medical Center |
Valentino L. et al. Haemophilia. 2015;21:559-567. |